Format

Send to

Choose Destination
Expert Rev Cardiovasc Ther. 2010 Feb;8(2):211-5. doi: 10.1586/erc.09.175.

Venous thromboembolism in women taking hormonal contraceptives.

Author information

1
Department of Internal Medicine, Hospital Universitario Reina Sofía, Córdoba, Spain. mablancom@telefonica.net

Abstract

Hormonal contraceptives are a popular method of contraception, but their use has been associated with an increased risk for venous thromboembolism. In order to reduce such risk, these compounds have been changed in their dosage, chemical composition and route of administration. The absolute risk of death from pulmonary embolism in contraceptive users has been estimated to be 10.5 (95% CI: 6.2-16.6) per million woman-years. The safest option is an oral contraceptive containing levonorgestrel combined with a low dose of estrogen. Identifying women at increased risk for venous thromboembolism is difficult, and greater use of thromboprophylaxis during immobility or minor surgery should be warranted. Several authors have called for all women to be screened for thrombophilia before prescription of hormonal contraceptives, but its cost-effectiveness remains uncertain.

PMID:
20136607
DOI:
10.1586/erc.09.175
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center